Michal Caspi Tal

7PUBLICATIONS
36CO-AUTHORS
Medical devicesBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Information systems for sustainable development and the public goodChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 21, 2026
Engineered mucus-tethering bispecific nanobodies enhance mucosal immunity against respiratory pathogens.

Liming Zhao, Kyle L O'Donnell, Megha Dubey

|Mar 20, 2024
SCGB1D2 inhibits growth of Borrelia burgdorferi and affects susceptibility to Lyme disease.

Satu Strausz, Erik Abner, Grace Blacker

|Dec 18, 2023
SIRPα controls CD47-dependent platelet clearance in mice and humans.

Maia Shoham, Ying Ying Yiu, Paige S Hansen

|Jul 11, 2022
Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS-CoV-2 infection.

Salma Sheikh-Mohamed, Erin C Sanders, Jennifer L Gommerman

|Mar 03, 2022
CD47 Blockade Leads to Chemokine-Dependent Monocyte Infiltration and Loss of B Cells from the Splenic Marginal Zone.

Ying Ying Yiu, Paige S Hansen, Laughing Bear Torrez Dulgeroff

|Jul 14, 2021
Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance.

Rosalynd Upton, Allison Banuelos, Dongdong Feng

Pageof 2